Dr. Pasquale Dell'api, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 29755 Overseas Hwy, Big Pine Key, FL 33043 Phone: 305-872-3735 Fax: 305-872-4792 |
Mr. David Frank Grider, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 29980 Overseas Hwy, Big Pine Key, FL 33043 Phone: 305-872-3321 Fax: 305-872-9062 |
News Archive
Cerapedics, a privately-held orthobiologics company, announced today the U.S. Food and Drug Administration (FDA) has approved the company's Premarket Approval (PMA) application for i-FACTORâ„¢ Peptide Enhanced Bone Graft for use in anterior cervical discectomy and fusion (ACDF) procedures in patients with degenerative cervical disc disease. i-FACTOR bone graft is the first bone graft to be approved for use in the cervical spine and only the second PMA-approved bone graft in the spine.
Women with early stage breast cancer who adopted a diet very high in vegetables, fruit and fiber and low in fat did not have a lower risk of breast cancer recurrence compared to women who followed a diet of five or more servings a day of fruit and vegetables (the "5-A-Day" diet), according to a study in the July 18 issue of JAMA: The Journal of the American Medical Association.
A recent study led by researchers from the Amyloidosis Center at Boston University School of Medicine and Boston Medical Center demonstrates that diflunisal, a generic anti-inflammatory drug, successfully reduced neurological decline and preserved the quality of life in patients with familial transthyretin amyloidosis. Diflunisal is an inexpensive and safe medication marketed over the past 40 years for arthritis and pain.
A new study at Columbia University Mailman School of Public Health found a consistent association between the adoption of state Prescription Drug Monitoring programs (PDMP) and death rates from heroin poisoning.
A new category of immunotherapies called checkpoint inhibitors that has been highly effective against many different cancers appears safe to use in patients with both advanced malignancies and HIV, a population excluded from earlier trials of such therapies, according to an early-phase trial.
› Verified 4 days ago